Saccharomyces boulardii and Reduced Hospitalization Duration

• Saccharomyces boulardii CNCM I-745 in different clinical conditions.

  • 2014-07-04
  • Review
  • Expert opinion on biological therapy 14(11)
  • • Ener Cagri Dinleyici
    • Ates Kara
    • Metehan Ozen
    • Yvan Vandenplas

  • PubMed: 24995675
  • DOI: 10.1517/14712598.2014.937419

  8 Insights on

  • Reduced Hospitalization Duration

  • Low evidence

  Saccharomyces boulardii is one of the best-studied probiotics in acute gastroenteritis (AGE) and is shown to be safe and to reduce the duration of diarrhea and hospitalization by about 1 day.

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes

  Dose

  not specified